Recombinant Human IL29 protein, His-SUMO-tagged
|Product Overview :||Recombinant Human IL29 protein(Q8IU54)(21-200aa), fused to N-terminal His-SUMO tag, was expressed in E. coli|
- Gene Information
- Related Products
|Source :||E. coli|
|Form :||If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol.
If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
|Molecular Mass :||36 kDa|
|Protein length :||21-200aa|
|Purity :||Greater than 90% as determined by SDS-PAGE.|
|Storage :||Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.|
|Reconstitution :||Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%.|
|Gene Name :||IL29 interleukin 29 (interferon, lambda 1) [ Homo sapiens ]|
|Official Symbol :||IL29|
|Synonyms :||IL29; interleukin 29 (interferon, lambda 1); interleukin 29; interleukin-29; IFNL1; IL 29; IFN-lambda-1; cytokine Zcyto21; interferon lambda-1; interferon-lambda-1; interferon, lambda 1; IL-29;|
|Gene ID :||282618|
|mRNA Refseq :||NM_172140|
|Protein Refseq :||NP_742152|
|UniProt ID :||Q8IU54|
|◆ Recombinant Protein|
|IL29-34H||Active Recombinant Human IL29 Protein, Animal Free||+Inquiry|
|IL29-5200H||Active Recombinant Human IL29 Protein||+Inquiry|
|IL29-2309H||Recombinant Human IL29 Protein, His-tagged||+Inquiry|
|IL29-1034P||Recombinant Pig IL29 Protein, His-tagged||+Inquiry|
|IL29-513H||Recombinant Human IL29 Protein||+Inquiry|
|IL29-5228HCL||Recombinant Human IL29 293 Cell Lysate||+Inquiry|
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Q&As (6)Ask a question
The dose of IL29 should be determined according to the specific disease and patient situation, and the most appropriate dose usually needs to be determined through clinical trials and individualized treatment.
IL29 and IL28 are two similar interferons that are similar in structure and function, but with some minor differences such as receptor affinity and signaling pathways.
IL29 is highly targeted and safe, and can stimulate the response of the own immune system, which has better therapeutic effect and fewer side effects than traditional drugs.
At present, there are no clear studies to prove that IL29 has a direct antioxidant effect, but it may indirectly affect oxidative stress response by regulating immune system function.
IL29 has potential in the treatment of rheumatoid arthritis, hepatitis B, psoriasis and other autoimmune diseases.
It may cause some mild side effects, such as fever, fatigue, headache, etc., but it is generally reversible, and serious side effects are rare.
Customer Reviews (3)Write a review
Detect whether recombinant IL-29 protein causes immune responses, including allergic reactions, to avoid potential safety concerns. -
The biological activity of recombinant IL-29 protein was verified by cell experiments, including its effects on target cells, such as inhibiting viral proliferation and enhancing immune response. At the same time, to understand its interaction with relevant signaling pathways, to further evaluate its efficacy. -
It has the function of inhibiting virus proliferation and enhancing immune response. -
Ask a Question for All IL29 Products
Required fields are marked with *
My Review for All IL29 Products
Required fields are marked with *